Home - Products - Others - Other Targets - Bis(4-nitrophenyl)phosphate, sodium salt

Bis(4-nitrophenyl)phosphate, sodium salt

CAS No. 4043-96-3

Bis(4-nitrophenyl)phosphate, sodium salt ( —— )

Catalog No. M23100 CAS No. 4043-96-3

Bis(4-nitrophenyl)phosphate, sodium salt is a PDE (Phosphodiesterase) substrate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 66 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bis(4-nitrophenyl)phosphate, sodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Bis(4-nitrophenyl)phosphate, sodium salt is a PDE (Phosphodiesterase) substrate.
  • Description
    Bis(4-nitrophenyl)phosphate, sodium salt is a PDE (Phosphodiesterase) substrate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4043-96-3
  • Formula Weight
    362.17
  • Molecular Formula
    C12H8N2NaO8P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC(=CC=C1[N+](=O)[O-])OP(=O)([O-])OC2=CC=C(C=C2)[N+](=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • P110

    Dynamin-related protein 1 (Drp1) inhibitor, inhibits Drp1 GTPase activity. Displays no effect on dynamin 1 or other mitochondrial dynamics-related proteins. Inhibits mitochondrial fission, dysfunction and reactive oxygen species (ROS) production in vitro. Reduces programmed cell death and improves cell viability by protecting mitochondrial integrity. Reduces mitochondrial fragmentation and mitochondrial ROS production in mouse model of Parkinson's disease. Cell permeable.

  • IFN-γ Antagonist

    IFN-γ Antagonist

  • IRL 2500

    IRL 2500 is an effective antagonist of the Endothelin receptor. IRL 2500 suppresses ETB receptor-mediated blood pressure increase and renal vascular resistance in rats in vivo.